University of Tennessee
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, University of Tennessee sits in the top decile of US sponsors by registered trial count (#245 of 15,742 sponsors by registered trial count).
University of Tennessee: 96 sponsored US clinical trials, 12 recruiting.
University of Tennessee sponsors 96 registered US clinical trials on ClinicalTrials.gov, 12 of them currently recruiting, and 71 completed. 14 of these trials are in Phase 3-4 (later-stage) and 16 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Chronic Lung Disease, with 2 trials.
Top-decile sponsor footprint
University of Tennessee ranks in the top decile of sponsors by registered trial count (#245 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
71 of 78 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
96 total, page 1 of 2
Pharmacokinetic Analysis of Cefiderocol in Patients With Acute Burn Injuries
NCT07465432
COMFORT Trial: Complex Obstetric Management With Focused Regional Transversus Abdominis Plane Block
NCT06925152
Making Healthy Habits Stick
NCT06745180
Postoperative Bladder Filling After Outpatient Laparoscopic Hysterectomy and Time to Discharge
NCT06737393
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
NCT06532708
Low-Dose Ketamine Infusion During Burn Wound Care
NCT06506565
Pain With Differing Insufflation Pressures During Laparoscopic Hysterectomy
NCT06508814
Does Starting Feeds on the First Day of Life Help Premature Infants Reach Full Volume Feeds Sooner?
NCT06731439
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
NCT06374277
Supporting Infant Development Through Tummy Time, Positioning, and Limiting Baby Gear
NCT05878275
Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment
NCT03686709
Pregnancies Complicated by Fetal Anomalies
NCT02505464
Investigating Proximal Muscle Strength Effects by Incorporating Proximal Muscle Lengthening
NCT05710757
Choosing Healthy Activities and Lifestyle Management Through Portal Support
NCT05410353
CBD Knee Osteoarthritis Study
NCT07638189
Access to Care Pilot for ED-Presenting Head and Neck Cancer Patients (ENRICH-HNC)
NCT07225725
Effects of UPF Warning Labels on Social Media Among Teens and Young Adults
NCT07227519
Pain with Differing Intraperitoneal Washes At the End of Laparoscopic Gynecologic Surgery
NCT06842771
Effects of Constipation Treatment in Chronic Kidney Disease: A Pilot Feasibility Trial
NCT06123195
The Healthy Eating and Active Living to Reverse Diabetes Pilot Study
NCT07316569
Oliceridine in Patients With Acute Burn Injuries
NCT05465226
The Effect of Placental Cord Drainage on Postpartum Blood Loss
NCT05610345
A Randomized Trial Evaluating EARLY Application of a Surfactant Dressing in Thermal Injury (EARLY)
NCT04880655
Opioid Reduction Program for Total Knee Replacement Patients
NCT05414942
Evaluation of SOMAVAC 100 Sustained Vacuum System
NCT04845256
Awareness Enhancing Interventions
NCT04683510
SMART Trial: Intrapersonal and Interpersonal Stigma Reduction
NCT04693416
Trial of Neurostimulation and Blood Flow Restriction for PFPS in Active Duty
NCT04086615
Analgesic Effects of Cannabidiol for Simple Tooth Extractions in Dental Patients
NCT04271917
Confirming Proper Replacement of Dislodged Gastrostomy Tubes in Pediatric Patients
NCT04331873
Gestational Weight and Incentive Research Study
NCT03834194
Alveolar Ridge Preservation Procedures
NCT05419778
Subacute Low Back Pain in Active Duty
NCT03502187
Efficacy of Two Novel Behavioral Post-cessation Weight Gain Interventions
NCT03156660
Opioid Physiology Project
NCT03462797
Para-cervical Block Prior to Laparoscopic Hysterectomy as an Adjuvant Treatment to Reduce Postoperative Pain.
NCT03027661
Gastrointestinal Microbiome Influence on the Development of Bronchopulmonary Dysplasia
NCT03229967
Real-time Glaucoma Medication Adherence
NCT03194828
Gestational Weight Gain and Postpartum Weight Loss in Active Duty Women (Moms Fit 2 Fight)
NCT03057808
Post-Operative Gynecological Oncology App Study
NCT02932098
IN Ketamine Vs IN Midazolam and Fentanyl for Abscess I&D
NCT02635282
Acetaminophen vs Indomethacin in Treating hsPDA
NCT03537144
Intestinal Permeability and Endometriosis
NCT03042923
Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy
NCT02786810
sFlt-1:PlGF Ratio in Diagnosing Superimposed Preeclampsia
NCT03441711
Beta Blockade in in Traumatic Brain Injury
NCT02957331
Web-Base App To Improve Aromatase Inhibitor Adherence
NCT02957526
Cold Therapy for Pain Control Following Caesarean Section
NCT03711994
Screening for Therapy and Empowering Parents: A Pilot Study
NCT04183504
Biophysical Profile in Preterm Pregnancies
NCT02561364
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 8 |
| Phase 2 | 8 |
| Phase 3 | 5 |
| Phase 4 | 9 |
What is open in the University of Tennessee pipeline
12 recruiting of 96 indexed (13% open); 71 completed (74%).
Phase mix: 14 late (III/IV) vs 16 early (I/II) (balanced across stages).
Top condition: Chronic Lung Disease (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Tennessee: open-pipeline peers nationwide
Peers matched on 96 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Tennessee sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 96 trials (± recruiting share)
- Masimo Corporation · 96 trials · 3% recruiting
- University of Mississippi Medical Center · 96 trials · 10% recruiting
- Arkansas Children's Hospital Research Institute · 97 trials · 19% recruiting
- AdventHealth · 95 trials · 17% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Addario Lung Cancer Medical Institute · 13% recruiting · 8 trials
- American University · 13% recruiting · 16 trials
- Annexon · 13% recruiting · 8 trials
- Ansun Biopharma · 13% recruiting · 8 trials
Related
What to do with this University of Tennessee page
96 registered trials is a research-attention snapshot, not an endorsement of University of Tennessee or any single study.
- 12 of University of Tennessee's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Chronic Lung Disease is the condition University of Tennessee studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Chronic Lung Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Tennessee pipeline card: 96 registered trials from official public datasets.Report a data error.